These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20810811)

  • 1. Effectiveness and feasibility of active and passive case detection in the visceral leishmaniasis elimination initiative in India, Bangladesh, and Nepal.
    Hirve S; Singh SP; Kumar N; Banjara MR; Das P; Sundar S; Rijal S; Joshi A; Kroeger A; Varghese B; Thakur CP; Huda MM; Mondal D
    Am J Trop Med Hyg; 2010 Sep; 83(3):507-11. PubMed ID: 20810811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active case detection in national visceral leishmaniasis elimination programs in Bangladesh, India, and Nepal: feasibility, performance and costs.
    Huda MM; Hirve S; Siddiqui NA; Malaviya P; Banjara MR; Das P; Kansal S; Gurung CK; Naznin E; Rijal S; Arana B; Kroeger A; Mondal D
    BMC Public Health; 2012 Nov; 12():1001. PubMed ID: 23164318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Options for active case detection of visceral leishmaniasis in endemic districts of India, Nepal and Bangladesh, comparing yield, feasibility and costs.
    Singh SP; Hirve S; Huda MM; Banjara MR; Kumar N; Mondal D; Sundar S; Das P; Gurung CK; Rijal S; Thakur CP; Varghese B; Kroeger A
    PLoS Negl Trop Dis; 2011 Feb; 5(2):e960. PubMed ID: 21347452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visceral leishmaniasis elimination programme in India, Bangladesh, and Nepal: reshaping the case finding/case management strategy.
    Mondal D; Singh SP; Kumar N; Joshi A; Sundar S; Das P; Siddhivinayak H; Kroeger A; Boelaert M
    PLoS Negl Trop Dis; 2009; 3(1):e355. PubMed ID: 19159009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of a combined camp approach for vector control together with active case detection of visceral leishmaniasis, post kala-azar dermal leishmaniasis, tuberculosis, leprosy and malaria in Bangladesh, India and Nepal: an exploratory study.
    Banjara MR; Kroeger A; Huda MM; Kumar V; Gurung CK; Das ML; Rijal S; Das P; Mondal D
    Trans R Soc Trop Med Hyg; 2015 Jun; 109(6):408-15. PubMed ID: 25918216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs and outcomes of active and passive case detection for visceral leishmaniasis (Kala-Azar) to inform elimination strategies in Bihar, India.
    Dial NJ; Medley GF; Croft SL; Mahapatra T; Priyamvada K; Sinha B; Palmer L; Terris-Prestholt F
    PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009129. PubMed ID: 33534836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical and environmental vector control as a contribution to the elimination of visceral leishmaniasis on the Indian subcontinent: cluster randomized controlled trials in Bangladesh, India and Nepal.
    Joshi AB; Das ML; Akhter S; Chowdhury R; Mondal D; Kumar V; Das P; Kroeger A; Boelaert M; Petzold M
    BMC Med; 2009 Oct; 7():54. PubMed ID: 19804620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vector control interventions for visceral leishmaniasis elimination initiative in South Asia, 2005-2010.
    Picado A; Dash AP; Bhattacharya S; Boelaert M
    Indian J Med Res; 2012 Jul; 136(1):22-31. PubMed ID: 22885260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation research to support the initiative on the elimination of kala azar from Bangladesh, India and Nepal--the challenges for diagnosis and treatment.
    Sundar S; Mondal D; Rijal S; Bhattacharya S; Ghalib H; Kroeger A; Boelaert M; Desjeux P; Richter-Airijoki H; Harms G
    Trop Med Int Health; 2008 Jan; 13(1):2-5. PubMed ID: 18290995
    [No Abstract]   [Full Text] [Related]  

  • 10. Integrating Case Detection of Visceral Leishmaniasis and Other Febrile Illness with Vector Control in the Post-Elimination Phase in Nepal.
    Banjara MR; Das ML; Gurung CK; Singh VK; Joshi AB; Matlashewski G; Kroeger A; Olliaro P
    Am J Trop Med Hyg; 2019 Jan; 100(1):108-114. PubMed ID: 30426921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How do health care providers deal with kala-azar in the Indian subcontinent?
    Kumar N; Singh SP; Mondal D; Joshi A; Das P; Sundar S; Kroeger A; Hirve S; Siddiqui NA; Boelaert M
    Indian J Med Res; 2011 Sep; 134(3):349-55. PubMed ID: 21985818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the impact of implementation research on the Visceral Leishmaniasis (VL) elimination efforts in Nepal.
    Joshi AB; Banjara MR; Chuke S; Kroeger A; Jain S; Aseffa A; Reeder JC
    PLoS Negl Trop Dis; 2023 Nov; 17(11):e0011714. PubMed ID: 37943733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Entomological efficacy of durable wall lining with reduced wall surface coverage for strengthening visceral leishmaniasis vector control in Bangladesh, India and Nepal.
    Huda MM; Kumar V; Das ML; Ghosh D; Priyanka J; Das P; Alim A; Matlashewski G; Kroeger A; Alfonso-Sierra E; Mondal D
    BMC Infect Dis; 2016 Oct; 16(1):539. PubMed ID: 27716091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elimination of visceral leishmaniasis in Nepal: pipe-dreams and possibilities.
    Joshi AB; Banjara MR; Pokhrel S; Jimba M; Singhasivanon P; Ashford RW
    Kathmandu Univ Med J (KUMJ); 2006; 4(4):488-96. PubMed ID: 18603960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human resource assessment for scaling up VL active case detection in Bangladesh, India and Nepal.
    Naznin E; Kroeger A; Siddiqui NA; Sundar S; Malaviya P; Mondal D; Huda MM; Das P; Karki P; Banjara MR; Dreesch N; Gedik G
    Trop Med Int Health; 2013 Jun; 18(6):734-42. PubMed ID: 23651494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Evaluation of Active Case Detection Methods to Support Visceral Leishmaniasis Elimination in India.
    Dubey P; Das A; Priyamvada K; Bindroo J; Mahapatra T; Mishra PK; Kumar A; Franco AO; Rooj B; Sinha B; Pradhan S; Banerjee I; Kumar M; Bano N; Kumar C; Prasad C; Chakraborty P; Kumar R; Kumar N; Kumar A; Singh AK; Kundan K; Babu S; Shah H; Karthick M; Roy N; Gill NK; Dwivedi S; Chaudhuri I; Hightower AW; Chapman LAC; Singh C; Sharma MP; Dhingra N; Bern C; Srikantiah S
    Front Cell Infect Microbiol; 2021; 11():648903. PubMed ID: 33842396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How far are we from visceral leishmaniasis elimination in Bangladesh? An assessment of epidemiological surveillance data.
    Chowdhury R; Mondal D; Chowdhury V; Faria S; Alvar J; Nabi SG; Boelaert M; Dash AP
    PLoS Negl Trop Dis; 2014 Aug; 8(8):e3020. PubMed ID: 25144317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model-based investigations of different vector-related intervention strategies to eliminate visceral leishmaniasis on the Indian subcontinent.
    Stauch A; Duerr HP; Picado A; Ostyn B; Sundar S; Rijal S; Boelaert M; Dujardin JC; Eichner M
    PLoS Negl Trop Dis; 2014 Apr; 8(4):e2810. PubMed ID: 24762676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Will visceral leishmaniasis be eliminated from Nepal? A review of recent (1994-2006) control efforts.
    Bhandari GP; Angdembe MR; Rijal S; Boelaert M
    Nepal Med Coll J; 2011 Sep; 13(3):220-5. PubMed ID: 22808821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visceral leishmaniasis in the Indian subcontinent: modelling epidemiology and control.
    Stauch A; Sarkar RR; Picado A; Ostyn B; Sundar S; Rijal S; Boelaert M; Dujardin JC; Duerr HP
    PLoS Negl Trop Dis; 2011 Nov; 5(11):e1405. PubMed ID: 22140589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.